UPMC Hillman Cancer Center

Meeting Schedule

Hillman PRC/PRMS committee meeting dates and deadlines for submission for 2017 are as follows:

COMMITTEE A
3:30-5:00pm, 5 East Conference Room
Andrew Laman, MD (Chairman)

COMMITTEE B
2:00-3:30pm, 5 East Conference Room
Leonard Appleman, MD (Chairman)

Deadline Dates For Submission Meeting Dates Deadline Dates For Submission Meeting Dates
December 20, 2016 January 9, 2017 January 5, 2017 January 23, 2017
January 19, 2017 February 6, 2017 February 2, 2017 February 20, 2017
February 16, 2017 March 6, 2017 March 2, 2017 March 20, 2017
*West CR
March 16, 2017 April 3, 2017 April 6, 2017 April 24, 2017
April 24, 2017 May 8, 2017 May 8, 2017 May 22, 2017
May 25, 2017 June 12, 2017
*West CR
June 12, 2017 June 26, 2017
June 29, 2017 July 17, 2017 July 17, 2017 July 31, 2017
July 28, 2017 August 14, 2017 August 10, 2017 August 28, 2017
August 28, 2017 September 11, 2017 September 11, 2017 September 25, 2017
September 25, 2017 October 9, 2017 October 9, 2017 October 23, 2017
October 23, 2017 November 6, 2017 November 6, 2017 November 20, 2017
November 20, 2017 December 4, 2017 December 4, 2017 December 18, 2017

Deadlines for submission to the PRC/PRMS are approximately 2 weeks before the scheduled meeting date. Please note that any trials lacking the required documentation for review by EOB on the dates listed above may not be guaranteed on the next meeting agenda.

Required documents include the following:

  1. A completed PRC/PRMS checklist/program director letter
  2. A copy of full protocol (unsecured)
  3. A sponsor and/or Hillman consent form
  4. Investigator drug brochure
  5. All trials must receive sign-off from the Disease Center Director and all investigator-initiated trials must be approved by a University of Pittsburgh Biostatistician prior to submission to the PRC/PRMS (signature on checklist).

Finalized documents can be emailed to Brandon Kaukus at kaukusbm@upmc.edu or call 412-623-3376 if you have any questions.

Note: Any studies with Chairman as PI should be sent to the opposite committee for review.